Axonics Modulation Technologies Inc Market Cap ($40.89 Million)
Market Cap & Net Worth: Axonics Modulation Technologies Inc (AXNX)
Axonics Modulation Technologies Inc market cap. Axonics Modulation Technologies Inc (NASDAQ:AXNX) has a market capitalization of $40.89 Million ($40.89 Million) as of October 29, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #22516 globally and #4970 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Axonics Modulation Technologies Inc's stock price $0.80 by its total outstanding shares 51109200 (51.11 Million).
Axonics Modulation Technologies Inc Market Cap History (2018–2026)
Axonics Modulation Technologies Inc market cap history from 2018 to 2026. Data shows change from $772.26 Million to $40.89 Million (-30.68% CAGR). Check AXNX stock price for real-time trading data and today's change.
Axonics Modulation Technologies Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Axonics Modulation Technologies Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see Axonics Modulation Technologies Inc (AXNX) cash conversion ratio for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
8.68x
Axonics Modulation Technologies Inc's market cap is 8.68 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $772.26 Million | $707.00K | -$32.48 Million | 1092.31x | N/A |
| 2019 | $1.42 Billion | $13.82 Million | -$79.94 Million | 102.48x | N/A |
| 2020 | $2.55 Billion | $111.53 Million | -$54.91 Million | 22.88x | N/A |
| 2021 | $2.86 Billion | $180.29 Million | -$80.07 Million | 15.88x | N/A |
| 2022 | $3.20 Billion | $273.70 Million | -$59.70 Million | 11.68x | N/A |
| 2023 | $3.18 Billion | $366.38 Million | -$6.09 Million | 8.68x | N/A |
Competitor Companies of AXNX by Market Capitalization
Companies near Axonics Modulation Technologies Inc in the global market cap rankings as of October 29, 2026. See Axonics Modulation Technologies Inc balance sheet quality to understand what proportion of total assets are financed by equity.
Key companies related to Axonics Modulation Technologies Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #120 globally with a market cap of $179.28 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #212 globally with a market cap of $115.62 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #242 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #120 | Abbott Laboratories | NYSE:ABT | $179.28 Billion | $103.10 |
| #212 | Stryker Corporation | NYSE:SYK | $115.62 Billion | $301.42 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $93.95 |
| #242 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Axonics Modulation Technologies Inc (2018–2026)
Market capitalization of Axonics Modulation Technologies Inc from 2018 to today. Between 2018 and today, Axonics Modulation Technologies Inc's market cap moved from $772.26 Million to $ 40.89 Million, with a yearly change of -30.68%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $40.89 Million | -98.87% |
| 2024 | $3.63 Billion | +14.06% |
| 2023 | $3.18 Billion | -0.48% |
| 2022 | $3.20 Billion | +11.66% |
| 2021 | $2.86 Billion | +12.18% |
| 2020 | $2.55 Billion | +80.15% |
| 2019 | $1.42 Billion | +83.39% |
| 2018 | $772.26 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 28th, 2026 the market cap of Axonics Modulation Technologies Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $40.89 Million USD |
| MoneyControl | $40.89 Million USD |
| MarketWatch | $40.89 Million USD |
| marketcap.company | $40.89 Million USD |
| Reuters | $40.89 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Axonics Modulation Technologies Inc
Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retent… Read more